Comments to FDA: Quality Attribute Considerations for Chewable Tablets

Share page:
Docket Number:
FDA-2016-D-1490

Our member companies generally support the recommendations found in the guidance but have concerns about the scope of hardness measurements and maximum break strength value.

Related Posts

CHPA Statement on Valisure Citizen Petition